These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30719508)

  • 1. Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.
    Harrop R; O'Neill E; Stern PL
    Ther Adv Vaccines Immunother; 2019; 7():2515135518821623. PubMed ID: 30719508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.
    Stern PL; Harrop R
    Cancer Immunol Immunother; 2017 Apr; 66(4):415-426. PubMed ID: 27757559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncofetal proteins and cancer stem cells.
    Yan Q; Fang X; Li C; Lan P; Guan X
    Essays Biochem; 2022 Sep; 66(4):423-433. PubMed ID: 35670043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4.
    Harper J; Lloyd C; Dimasi N; Toader D; Marwood R; Lewis L; Bannister D; Jovanovic J; Fleming R; D'Hooge F; Mao S; Marrero AM; Korade M; Strout P; Xu L; Chen C; Wetzel L; Breen S; van Vlerken-Ysla L; Jalla S; Rebelatto M; Zhong H; Hurt EM; Hinrichs MJ; Huang K; Howard PW; Tice DA; Hollingsworth RE; Herbst R; Kamal A
    Mol Cancer Ther; 2017 Aug; 16(8):1576-1587. PubMed ID: 28522587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.
    Southgate TD; McGinn OJ; Castro FV; Rutkowski AJ; Al-Muftah M; Marinov G; Smethurst GJ; Shaw D; Ward CM; Miller CJ; Stern PL
    PLoS One; 2010 Apr; 5(4):e9982. PubMed ID: 20376365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective antitumor activity of 5T4-specific CAR-T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo.
    Guo C; Dong E; Lai Q; Zhou S; Zhang G; Wu M; Yue X; Tao Y; Peng Y; Ali J; Lu Y; Fu Y; Lai W; Zhang Z; Ma F; Yao Y; Gou L; Yang H; Yang J
    MedComm (2020); 2020 Dec; 1(3):338-350. PubMed ID: 34766126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and exploiting 5T4 oncofoetal glycoprotein expression.
    Stern PL; Brazzatti J; Sawan S; McGinn OJ
    Semin Cancer Biol; 2014 Dec; 29():13-20. PubMed ID: 25066861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on immune-based therapy strategies targeting cancer stem cells.
    Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
    Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells.
    Guo X; Zheng H; Luo W; Zhang Q; Liu J; Yao K
    Sci Rep; 2017 Jul; 7(1):4859. PubMed ID: 28687750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in drug delivery systems for targeting cancer stem cells.
    Duan H; Liu Y; Gao Z; Huang W
    Acta Pharm Sin B; 2021 Jan; 11(1):55-70. PubMed ID: 33532180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic strategies for targeting liver cancer stem cells.
    Oishi N; Wang XW
    Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
    Kapoor-Narula U; Lenka N
    Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways.
    MacLean MR; Walker OL; Arun RP; Fernando W; Marcato P
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models.
    Smith RA; Zammit DJ; Damle NK; Usansky H; Reddy SP; Lin JH; Mistry M; Rao NS; Denis LJ; Gupta S
    Mol Cancer Ther; 2021 Aug; 20(8):1327-1337. PubMed ID: 34045226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
    Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
    Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways in the regulation of cancer stem cells and associated targeted therapy.
    Manni W; Min W
    MedComm (2020); 2022 Dec; 3(4):e176. PubMed ID: 36226253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concise review on the current understanding of pancreatic cancer stem cells.
    Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
    J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.